| Issue |
Section |
Title |
File |
| Vol 96, No 1 (2020) |
CLINICAL PRACTICE GUIDELINES |
Combination treatment of disseminated granuloma annulare |
(Rus)
|
| Vol 96, No 1 (2020) |
SHORT COMMUNICATION |
Congenital epidermolysis bullosa: modern methods of diagnosis and therapy. Prospects for regenerative medicine |
(Rus)
|
| Vol 96, No 1 (2020) |
CLINICAL CASE REPORTS |
IgG/IgA-pemphigus — extremely rare blistering autoimmune diseases |
(Rus)
|
| Vol 96, No 3 (2020) |
CLINICAL CASE REPORTS |
Erythema nodosum as Leprosy reaction |
(Rus)
|
| Vol 96, No 6 (2020) |
ORIGINAL STUDIES |
Skin cytokine profile in patients with mycosis fungoides |
(Rus)
|
| Vol 97, No 4 (2021) |
REVIEWS |
Revisiting the question of cutaneous vasculitis classification |
(Rus)
|
| Vol 97, No 4 (2021) |
REVIEWS |
Genetic markers for psoriatic arthritis in patients with psoriasis. Part I: non-HLA genes |
(Rus)
|
| Vol 97, No 6 (2021) |
CLINICAL CASE REPORTS |
Melanoma in patients with mycosis fungoides |
(Rus)
|
| Vol 97, No 6 (2021) |
REVIEWS |
Topical treatment of inherited epidermolysis bullosa |
(Rus)
|
| Vol 98, No 2 (2022) |
ORIGINAL STUDIES |
Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial |
(Rus)
|
| Vol 98, No 3 (2022) |
GUIDELINES FOR PRACTITIONERS |
Assessment of the severity of atopic dermatitis — SCORAD and EASI |
(Rus)
|
| Vol 98, No 5 (2022) |
REVIEWS |
Revisiting the question of toxidermia classification |
(Rus)
|
| Vol 98, No 5 (2022) |
REVIEWS |
HLA-B27 and its role in the pathogenesis of psoriatic arthritis |
(Rus)
|
| Vol 98, No 6 (2022) |
REVIEWS |
Revisiting the question of assessment by severity and classification of acne |
(Rus)
|
| Vol 98, No 6 (2022) |
REVIEWS |
Phototherapy combined with systemic agents for mycosis fungoides |
(Rus)
|
| Vol 98, No 6 (2022) |
REVIEWS |
Junctional epidermolysis bullosa: genotype-phenotype correlations |
(Rus)
|
| Vol 99, No 4 (2023) |
REVIEWS |
Dystrophic epidermolysis bullosa: genotype-phenotype correlations |
(Rus)
|
| Vol 99, No 4 (2023) |
ORIGINAL STUDIES |
Current state of equipment for phototherapy in institutions of dermatovenereologic profile |
(Rus)
|
| Vol 99, No 5 (2023) |
ORIGINAL STUDIES |
Search for predictors of psoriatic arthritis in patients with psoriasis |
(Rus)
|
| Vol 99, No 5 (2023) |
CLINICAL CASE REPORTS |
Case report of leprosy in the Russian Federation |
(Rus)
|
| Vol 99, No 5 (2023) |
ORIGINAL STUDIES |
Narrow-band UVB phototherapy in patients with atopic dermatitis: analysis of the factors determining treatment efficacy |
(Rus)
|
| Vol 99, No 6 (2023) |
REVIEWS |
PUVA photochemotherapy for the patients with atopic dermatitis |
(Rus)
|
| Vol 99, No 6 (2023) |
ORIGINAL STUDIES |
Efficacy of human living skin equivalent in the treatment of inherited epidermolysis bullosa |
(Rus)
|
| Vol 100, No 1 (2024) |
REVIEWS |
Deficient skin proteins rescue of expression in patients with epidermolysis bullosa: efficacy of gentamicin |
(Rus)
|
| Vol 100, No 4 (2024) |
CLINICAL CASE REPORTS |
Paraneoplastic pembigus: clinical and diagnostic features |
(Rus)
|
| Vol 100, No 5 (2024) |
REVIEWS |
Application of biomedical cell products in the treatment of congenital epidermolysis bullosa |
(Rus)
|
| Vol 100, No 5 (2024) |
CLINICAL CASE REPORTS |
Effectiveness of rituximab in the treatment of patients with pemphigus vulgarus |
(Rus)
|
| Vol 100, No 6 (2024) |
REVIEWS |
Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids |
(Rus)
|
| Vol 100, No 5 (2024) |
GUIDELINES FOR PRACTITIONERS |
Dermoscopy in the diagnosis of mycosis fungoides |
(Rus)
|
| Vol 101, No 1 (2025) |
ORIGINAL STUDIES |
Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab |
(Rus)
|
| Vol 100, No 6 (2024) |
ORIGINAL STUDIES |
Current state of dermatovenereological medical organizations’ equipment for dermascopy |
(Rus)
|
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).